>
Big Rock Partners Acquisition logo

BRPAR - Big Rock Partners Acquisition Share Price

$2.29 -0.2  -8.0%

Last Trade - 24/05/21

Sector
Healthcare
Size
Small Cap
Market Cap £156.2m
Enterprise Value £127.9m
Revenue £n/a
Position in Universe th / 7397
Bullish
Bearish
Unlock BRPAR Revenue
Momentum
Relative Strength (%)
1m +39.1%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
+983.3
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2021, NRXPharmaceuticals Inc revenues was not reported. Net lossapplicable to common stockholders increased from $2K to$318.1M. Basic Earnings per Share excluding ExtraordinaryItems decreased from -$0.01 to -$7.55.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BRPAR Revenue Unlock BRPAR Revenue

Net Income

BRPAR Net Income Unlock BRPAR Revenue

Normalised EPS

BRPAR Normalised EPS Unlock BRPAR Revenue

PE Ratio Range

BRPAR PE Ratio Range Unlock BRPAR Revenue

Dividend Yield Range

BRPAR Dividend Yield Range Unlock BRPAR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2022
31st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
BRPAR EPS Forecasts Unlock BRPAR Revenue
Profile Summary

NRX Pharmaceuticals, Inc., formerly Big Rock Partners Acquisition Corp., is a patient-focused, clinical stage pharmaceutical company. The Company is focused on developing NRX-101. NRX-101 is an oral therapeutic for the treatment of Acute Suicidal Behavior/Ideation (ASIB) in Bipolar Disorder and ZYESAMI (aviptadil), an intravenous and inhaled drug to treat respiratory failure in COVID-19. NRX-101 is designed to offer an oral, rapid-onset and sustained home-use therapy that can extend ketamine’s anti-suicidal benefit and reduce the side effects of ketamine. The Company combines D-cycloserine (DCS), a N-methyl-D-aspartate (NMDA) receptor modulator, and lurasidone, a 5-HT2a receptor antagonist. NRX-101 is in Phase III of clinical testing.

Directors
Last Annual December 31st, 2020
Last Interim September 30th, 2021
Incorporated September 18, 2017
Public Since November 20, 2017
No. of Shareholders: 6
No. of Employees: 2
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange NASDAQ Capital Market (Dual Listing)
Shares in Issue 58,810,338
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BRPAR Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BRPAR
Upcoming Events for BRPAR
Frequently Asked Questions for Big Rock Partners Acquisition
What is the Big Rock Partners Acquisition share price?

As of 24/05/21, shares in Big Rock Partners Acquisition are trading at $2.29, giving the company a market capitalisation of £156.2m. This share price information is delayed by 15 minutes.

How has the Big Rock Partners Acquisition share price performed this year?

Shares in Big Rock Partners Acquisition are currently trading at $2.29 and the price has moved by 1.96k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Big Rock Partners Acquisition price has moved by 1.66k% over the past year.

What are the analyst and broker recommendations for Big Rock Partners Acquisition?

There are no analysts currently covering Big Rock Partners Acquisition.

When will Big Rock Partners Acquisition next release its financial results?

Big Rock Partners Acquisition is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-09-30
What is the Big Rock Partners Acquisition dividend yield?

Big Rock Partners Acquisition does not currently pay a dividend.

Does Big Rock Partners Acquisition pay a dividend?

Big Rock Partners Acquisition does not currently pay a dividend.

When does Big Rock Partners Acquisition next pay dividends?

Big Rock Partners Acquisition does not currently pay a dividend.

How do I buy Big Rock Partners Acquisition shares?

To buy shares in Big Rock Partners Acquisition you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Big Rock Partners Acquisition?

Shares in Big Rock Partners Acquisition are currently trading at $2.29, giving the company a market capitalisation of £156.2m.

Where are Big Rock Partners Acquisition shares listed? Where are Big Rock Partners Acquisition shares listed?

Here are the trading details for Big Rock Partners Acquisition:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: BRPAR
What kind of share is Big Rock Partners Acquisition?

We were not able to load our ranking data for Big Rock Partners Acquisition

Is there a Big Rock Partners Acquisition share price forecast 2022?

We were not able to load any forecast data for Big Rock Partners Acquisition.

How can I tell whether the Big Rock Partners Acquisition share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Big Rock Partners Acquisition. Over the past six months, the relative strength of its shares against the market has been 0.826k%. At the current price of $2.29, shares in Big Rock Partners Acquisition are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Big Rock Partners Acquisition PE Ratio?

We were not able to find PE ratio data for Big Rock Partners Acquisition.

Who are the key directors of Big Rock Partners Acquisition?

We were unable to find the directors for Big Rock Partners Acquisition.

Who are the major shareholders of Big Rock Partners Acquisition?

Here are the top five shareholders of Big Rock Partners Acquisition based on the size of their shareholding:

Similar to BRPAR
© Stockopedia 2022, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.